New device to test effects of drugs, disease on brain

Image
Press Trust of India Washington
Last Updated : Dec 19 2017 | 6:50 PM IST
Scientists have developed a 'brain-on-a-chip' device that could help test and predict the effects of biological and chemical agents, disease, or drugs on the brain, without the need for human or animal subjects.
The device simulates the central nervous system by recording neural activity from multiple brain cell types deposited and grown onto microelectrode arrays.
The research, published in the journal PLOS One, could help scientists understand how brain cells connect and interact, combat brain disorders, determine how soldiers are affected by exposure to chemical and biological weapons and develop antidotes to counteract those effects.
"While we are not close to the point where we can fully recapitulate a brain outside of the body, this is an important step in terms of increasing complexity of these devices and moving in the right direction," said Dave Soscia from Lawrence Livermore National Laboratory in the US.
"The idea is that eventually the community gets to a point where people are confident enough in the devices that the effects they see from putting chemicals or pharmaceutical drugs into the platform environment are similar to the results we would see in the human body," said Soscia.
To recreate the regions of the brain, researchers divided the chip into four distinct areas - three sub-regions and an external region representing the brain's cortex.
They deposited primary hippocampal and cortical cells onto the electrodes, positioned based on their relative orientation in the brain, using custom-built inserts that can be removed after the cells are placed in the device to allow free communication among the different regions.
The team then monitored the cells' action potential patterns - the "bursts" of electrical energy that cells emit when communicating - and observed how the cells interacted over time.
The researchers also successfully performed tests with a four-cell insert, to prove more cell types could be used simultaneously.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 19 2017 | 6:50 PM IST

Next Story